Gender Differences in COVID-19 Among Liver Transplant Recipients: Results from a Multicenter Brazilian Cohort

Gender Differences in COVID-19 Among Liver Transplant Recipients: Results from a Multicenter Brazilian Cohort

Blog Article

Introduction: Existing literature presents varying perspectives on the impact of COVID-19 on liver transplant recipients.However, no research has specifically investigated the role of gender differences in the manifestation of COVID-19 among liver transplant recipients.This study aims to examine the effects of COVID-19 on liver transplant recipients, with a focus on gender differences in disease presentation and progression.Methods: Conducted as a multicenter historical cohort study, this research collected patient records through turbo air m3f72-3-n an online questionnaire.

Assessing COVID-related mortality was the main objective.Additionally, demographic, clinical, and laboratory data pertaining to disease presentation and progression werecollected.Results: The study included a total of 283 patients, of whom 76 were female and 206 were male.The median follow-up period for males was 99 days (IQR 38-283), while for females, it was 126 days (IQR turbosound ts-18sw700/8a 44-291).

A higher prevalence of cardiovascular disease was observed in males (p=0.002).Females frequently experienced a loss of smell (p=0.021), whereas males commonly exhibited fever (p=0.

031).Levels of ALT and gamma-glutamyl transferase were significantly elevated in males (p=0.008 and 0.004, respectively).

Although there was a trend towards increased mortality in males, it did not reach statistical significance.Conclusion: This study is the first attempt to investigate gender differences in COVID-19 among liver transplant recipients.Our findings highlight the need for a comprehensive and personalised approach to treating this patient population and underscore the importance of further elucidating the disease presentation in these individuals.